Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Micr1on Jul 30, 2010 3:54pm
575 Views
Post# 17311851

RE: RE: SSS TARGETS - PURE BS

RE: RE: SSS TARGETS - PURE BSI suggest you be a little less agressive with a respected long holder of SSS.  STKGUY as been here for quite a while and has a right to speak is mind if he wants to.  And his comments express not only speculation but thoughts about facts of this company and the risk involved.  He is absolutely right about the importance of the end of August results; if we don't see nice trends in there, we are in trouble IMHO.

Basically CJ what I'm saying is be as balanced in your comments as STKGUY was.  He's been here long before you have.

Micr1
Bullboard Posts